.

Insulet traded at $232.97 this Monday October 3rd, increasing $3.57 or 1.56 percent since the previous trading session. Looking back, over the last four weeks, Insulet gained 6.73 percent. Over the last 12 months, its price fell by 16.62 percent. Looking ahead, we forecast Insulet to be priced at 222.52 by the end of this quarter and at 203.09 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 262.82 7.67 3.01% -16.26%
Abbott 101.25 1.73 1.74% -12.36%
Align Technology 224.17 8.53 3.96% -65.00%
AtriCure 40.01 0.91 2.33% -40.47%
Avanos Medical Inc 22.41 0.63 2.89% -28.59%
Baxter International 56.76 1.14 2.05% -29.42%
Becton, Dickinson and Co. 233.30 2.52 1.09% -4.02%
Boston Scientific 40.55 0.67 1.68% -4.39%
Cardinal Health 68.32 0.35 0.51% 37.93%
Cooper Companies 275.55 2.29 0.84% -33.60%
Cardiovascular Systems 14.10 0.24 1.73% -56.74%
Dexcom 89.53 4.55 5.35% -31.97%
Edwards Lifesciences 87.73 2.27 2.66% -19.39%
Globus Medical 60.85 1.28 2.15% -20.87%
Integra LifeSciences 43.84 1.48 3.49% -35.00%
ICU Medical 152.37 1.77 1.18% -34.66%
Inogen 24.32 0.04 0.16% -43.24%
J&J 164.48 1.28 0.78% 3.30%
Eli Lilly 325.47 3.92 1.22% 44.75%
Masimo 144.54 3.38 2.39% -45.75%
Medtronic 83.85 1.15 1.39% -33.35%
Merit Medical Systems 57.93 1.42 2.51% -17.83%
NuVasive 43.96 0.15 0.34% -26.94%
Insulet 232.97 3.57 1.56% -16.62%
Roche Holding 331.30 9.20 2.86% -4.37%
Sientra 0.69 0.05 8.20% -87.15%
Stryker 212.79 2.95 1.41% -18.93%
Teleflex 210.22 1.72 0.82% -43.84%
Tandem Diabetes Care 50.59 2.74 5.73% -57.19%
West Pharmaceutical Services 259.81 3.88 1.51% -36.61%
Zimmer Biomet Holdings Inc 109.17 1.85 1.72% -25.60%

Indexes Price Day Year
USND 10815 239.82 2.27% -24.13%
US2000 1709 44.15 2.65% -22.94%

Insulet
Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.